Gilead Sciences Stock Five Year Return
GILD34 Stock | BRL 287.56 4.47 1.58% |
Gilead Sciences fundamentals help investors to digest information that contributes to Gilead Sciences' financial success or failures. It also enables traders to predict the movement of Gilead Stock. The fundamental analysis module provides a way to measure Gilead Sciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Gilead Sciences stock.
Gilead |
Gilead Sciences Company Five Year Return Analysis
Gilead Sciences' Five Year Return is considered one of the best measures to evaluate fund performance, especially from the mid and long term perspective. It shows the total annualized return generated from holding equity for the last five years and represents capital appreciation of the investment, including all dividends, losses, and capital gains distributions.
More About Five Year Return | All Equity Analysis
Five Year Return | = | (Mean of Monthly Returns - 1) | X | 100% |
Although Five Year Returns can give a sense of overall investment potential, it is recommended to compare equity performance with similar assets for the same five year time interval. Similarly, comparing overall investment performance over the last five years with the appropriate market index is a great way to determine how this equity instrument will perform during unforeseen market fluctuations.
Competition |
According to the company disclosure, Gilead Sciences has a Five Year Return of 0.0%. This indicator is about the same for the Healthcare average (which is currently at 0.0) sector and about the same as Drug Manufacturers - Major (which currently averages 0.0) industry. This indicator is about the same for all Brazil stocks average (which is currently at 0.0).
Did you try this?
Run Portfolio File Import Now
Portfolio File ImportQuickly import all of your third-party portfolios from your local drive in csv format |
All Next | Launch Module |
Gilead Fundamentals
Return On Equity | 0.22 | |||
Return On Asset | 0.1 | |||
Profit Margin | 0.17 % | |||
Operating Margin | 0.40 % | |||
Current Valuation | 686.18 B | |||
Shares Outstanding | 2.49 B | |||
Price To Earning | 28.35 X | |||
Price To Book | 5.30 X | |||
Price To Sales | 21.27 X | |||
Revenue | 27.28 B | |||
Gross Profit | 21.62 B | |||
EBITDA | 6.75 B | |||
Net Income | 4.59 B | |||
Cash And Equivalents | 28.36 B | |||
Cash Per Share | 22.39 X | |||
Total Debt | 25.18 B | |||
Debt To Equity | 117.00 % | |||
Current Ratio | 3.76 X | |||
Book Value Per Share | 17.01 X | |||
Cash Flow From Operations | 9.07 B | |||
Earnings Per Share | 9.63 X | |||
Price To Earnings To Growth | 0.71 X | |||
Number Of Employees | 31 | |||
Beta | 0.41 | |||
Market Capitalization | 572.2 B | |||
Total Asset | 63.17 B | |||
Z Score | 13.2 | |||
Annual Yield | 0.03 % | |||
Net Asset | 63.17 B | |||
Last Dividend Paid | 2.92 |
About Gilead Sciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Gilead Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Gilead Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Gilead Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Information and Resources on Investing in Gilead Stock
When determining whether Gilead Sciences is a strong investment it is important to analyze Gilead Sciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Gilead Sciences' future performance. For an informed investment choice regarding Gilead Stock, refer to the following important reports:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Gilead Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For information on how to trade Gilead Stock refer to our How to Trade Gilead Stock guide.You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.